BUSINESS BITES: Kips Bay goes down with poor trial results; Qiagen, Biotype forms JV; from Russia, affordable diagnostics
This article was originally published in Clinica
Executive Summary
Kips Bay Medical, a company headed by medtech veteran Manny Villafana, is calling it quits after its eSVS Mesh for coronary bypass graft surgery performed poorly in the feasibility trial.